About Contact Us Careers

Lung Assessment Device Market Size and Forecast, by Type (Spirometers, Nebulizers), End-user (Hospitals, Home Care, Diagnostic Laboratories) - Growth Trends, Key Players, Regional Analysis 2026-2035

  • Report ID: 5210
  • Published Date: Nov 25, 2025
  • Report Format: PDF, PPT

Lung Assessment Device Market Outlook:

Lung Assessment Device Market size was valued at USD 15.25 billion in 2025 and is expected to reach USD 29.72 billion by 2035, registering around 6.9% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of lung assessment device is evaluated at USD 16.2 billion.

Lung Assessment Device Market Size
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

The market has been driven by factors such as the increasing prevalence of respiratory diseases, a growing aging population susceptible to such conditions, technological advancements in device design and connectivity, and a greater focus on early disease detection and management. The trend towards personalized and home-based healthcare has also contributed to the demand for portable and user-friendly lung assessment devices.

The lung assessment device market refers to the industry involved in the development, manufacturing, and distribution of medical devices designed to assess various aspects of lung health and function. These devices play a crucial role in diagnosing and monitoring respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), lung infections, and more. They are commonly used by healthcare professionals in hospitals, clinics, and home care settings.

Key Lung Assessment Device Market Insights Summary:

  • Regional Highlights:

    • Across 2026–2035, the Asia Pacific region is forecast to command a 38% revenue share by 2035 in the lung assessment device market, stemming from the escalating burden of respiratory diseases.
    • Over 2026–2035, the North America region is projected to secure the second-largest share by 2035, attributed to the high prevalence of respiratory disorders.

  • Segment Insights:

    • By 2035, the nebulizers segment in the lung assessment device market is projected to secure a 60% share, propelled by technological advancements in nebulizer design and functionality.
    • The hospitals segment is anticipated to capture a notable share by 2035, supported by its essential role in timely and accurate respiratory evaluation aimed at improving patient outcomes.

  • Key Growth Trends:

    • Escalating Prevalence of Respiratory Disorders
    • Growing Emphasis on Early Diagnosis and Prevention

  • Major Challenges:

    • Technological Complexity and Integration
    • Accuracy and Reliability

  • Key Players: Philips Healthcare, Medtronic, Masimo Corporation, GE Healthcare, BD (Becton, Dickinson and Company), Smiths Medical, Teleflex Incorporated, Fisher & Paykel Healthcare, Nihon Kohden Corporation, CareFusion Corporation.

Global Lung Assessment Device Market Forecast and Regional Outlook:

  • Market Size & Growth Projections:

    • 2025 Market Size: USD 15.25 billion
    • 2026 Market Size: USD 16.2 billion
    • Projected Market Size: USD 29.72 billion by 2035
    • Growth Forecasts: 6.9%

  • Key Regional Dynamics:

    • Largest Region: Asia Pacific (38% Share by 2035)
    • Fastest Growing Region: Asia Pacific
    • Dominating Countries: United States, China, Germany, Japan, United Kingdom
    • Emerging Countries: India, South Korea, Brazil, Mexico, Indonesia

    • Last updated on : 25 November, 2025

Growth Drivers

  • Escalating Prevalence of Respiratory Disorders – The escalating incidence of respiratory disorders, such as asthma, chronic obstructive pulmonary disease (COPD), and lung infections, is a driving force behind the expansion of the Lung Assessment Device sector. According to the World Health Organization (WHO), approximately 235 million individuals suffer from asthma globally, and over 3 million deaths are attributed to COPD each year.

  • Growing Emphasis on Early Diagnosis and Prevention: The shift towards proactive healthcare and preventive measures is propelling the demand for lung assessment devices that aid in early diagnosis. Early detection of respiratory conditions allows for timely intervention and better management.

  • Home-based Healthcare and Patient Empowerment: The trend towards home-based healthcare is fostering the development of portable lung assessment devices that empower patients to monitor their respiratory health. This trend is gaining traction, particularly in the wake of the COVID-19 pandemic.

Challenges

  • Technological Complexity and Integration: The rapid evolution of technology, while beneficial, brings forth challenges related to device complexity and seamless integration. Designing and implementing advanced features such as wireless connectivity, real-time data transmission, and user-friendly interfaces require significant engineering expertise. Ensuring compatibility and ease of use across various platforms and devices can be a substantial undertaking.

  • Accuracy and Reliability

  • Regulatory Compliance

Lung Assessment Device Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Year

2026-2035

CAGR

6.9%

Base Year Market Size (2025)

USD 15.25 billion

Forecast Year Market Size (2035)

USD 29.72 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Lung Assessment Device Market Segmentation:

Type Segment Analysis

The nebulizers segment is estimated to gain the largest market share of 60% in the year 2035. Technological advancements in nebulizer design and functionality are driving the demand for these devices. The development of portable and compact nebulizers allows patients to receive treatments conveniently at home or on-the-go. Smart nebulizers equipped with connectivity features enable real-time monitoring and data sharing between patients and healthcare providers. The industry of smart inhalers and nebulizers is projected to grow by 26% by the year 2025.

End User Segment Analysis

The hospitals segment is expected to garner a significant share in the year 2035. Hospitals play a vital role in critical care and disease management for patients with severe respiratory conditions. Lung assessment devices are instrumental in monitoring patients in intensive care units (ICUs) and guiding interventions for optimal ventilation and oxygenation. Timely and accurate assessment is crucial for improving patient outcomes. A study found that proper lung assessment and management in critically ill patients significantly impact mortality rates and overall patient care.

Our in-depth analysis of the global market includes the following segments:

             Type

  • Spirometers
  • Nebulizers

 

   

            End User
  • Hospitals
  • Home Care
  • Diagnostic Laboratories
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Lung Assessment Device Market - Regional Analysis

APAC Market Insights

Asia Pacific industry is predicted to dominate majority revenue share of 38% by 2035. The Asia Pacific region is a dynamic hub of healthcare innovation, witnessing remarkable growth in the market. As the region experiences demographic shifts, technological advancements, and evolving healthcare systems, the demand for accurate lung assessment tools is surging. The escalating burden of respiratory diseases across the Asia Pacific region is a significant driver for the market. Rapid urbanization, pollution, and changing lifestyles contribute to the rising prevalence of conditions such as asthma and chronic obstructive pulmonary disease (COPD), necessitating advanced lung assessment devices.

North American Market Insights

The lung assessment device market in the North America region is projected to hold the second largest share during the forecast period. The high prevalence of respiratory disorders in North America serves as a significant driver for the market. Conditions such as asthma, chronic obstructive pulmonary disease (COPD), and respiratory infections are common in the region. The demand for accurate lung assessment devices for diagnosis, monitoring, and treatment is consequently robust. The American Lung Association reports that over 35 million Americans are living with asthma, and COPD affects around 16 million people in the United States.

Lung Assessment Device Market Share
Get Strategic Analysis by Region Now: Request Free Sample PDF

Lung Assessment Device Market Players:

    • Philips Healthcare
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Medtronic
    • Masimo Corporation
    • GE Healthcare
    • BD (Becton, Dickinson and Company)
    • Smiths Medical
    • Teleflex Incorporated
    • Fisher & Paykel Healthcare
    • Nihon Kohden Corporation
    • CareFusion Corporation

Recent Developments

  • On August 14, 2023, Exor announced that it had acquired a 10% stake in Philips for USD 10 billion. Exor is a holding company that invests in a variety of industries, including healthcare. The investment is seen as a vote of confidence in Philips' strategy and its commitment to innovation in healthcare.
  • On August 2, 2023, Philips announced that CEO Roy Jakobs had been appointed co-chair of the US National Academy of Medicine's Steering Committee on an AI Code of Conduct. The committee is tasked with developing a set of ethical principles for the development and use of artificial intelligence in healthcare.
  • Report ID: 5210
  • Published Date: Nov 25, 2025
  • Report Format: PDF, PPT
  • Explore a preview of key market trends and insights
  • Review sample data tables and segment breakdowns
  • Experience the quality of our visual data representations
  • Evaluate our report structure and research methodology
  • Get a glimpse of competitive landscape analysis
  • Understand how regional forecasts are presented
  • Assess the depth of company profiling and benchmarking
  • Preview how actionable insights can support your strategy

Explore real data and analysis

Download Free Sample Report

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of lung assessment device is evaluated at USD 16.2 billion.

The global lung assessment device market size was worth around USD 15.25 billion in 2025 and is set to register a CAGR of more than 6.9%, exceeding USD 29.72 billion revenue by 2035.

Across 2026-2035, the Asia Pacific region is forecast to command a 38% revenue share by 2035 in the lung assessment device market, stemming from the escalating burden of respiratory diseases.

Key players in the market include Philips Healthcare, Medtronic, Masimo Corporation, GE Healthcare, BD (Becton, Dickinson and Company), Smiths Medical, Teleflex Incorporated, Fisher & Paykel Healthcare, Nihon Kohden Corporation, CareFusion Corporation.

Lung Assessment Device Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Get a Free Sample

See how top U.S. companies are managing market uncertainty — get your free sample with trends, challenges, macroeconomic factors, charts, forecasts, and more.

Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos